Use of chondroitin sulphate E (CS-E) for the treatment diseases or conditions related to collagen fibril formation.

Details for Australian Patent Application No. 2005235171 (hide)

International Classifications

Event Publications

30 November 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 03 Nov 2006

30 November 2006 PCT application entered the National Phase

PCT publication WO2005/102362 Priority application(s): WO2005/102362

23 October 2008 Amendment Made

The nature of the amendment is: Amend the name of the co-inventor to read from Aspberg, Angers to Aspberg, Anders

11 November 2010 Application Accepted

Published as AU-B-2005235171

10 March 2011 Standard Patent Sealed

23 June 2011 Alteration of Name

The name of the patentee has been altered to AnaMar AB

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.